Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Adc therapeutics sa source : Www.biospace.com save search
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 0.4%
H: 7.17%
C: 1.39%
merck
Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors
Published: 2023-11-15 (Crawled : 12:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -0.2%
H: 8.49%
C: 6.36%
biotech
Myricx Expands its ADC Expertise with the Appointment of Francesca Zammarchi as CSO
Published: 2023-10-04 (Crawled : 12:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 0.05%
H: 3.91%
C: -0.1%
ADC Therapeutics Announces Updated Results from LOTIS-2 Trial to be Presented at the European Hematology Association 2023 Hybrid Congress
Published: 2023-05-11 (Crawled : 19:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 0.83%
H: 7.02%
C: -0.41%
association trial therapeutics results
ADC Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
Published: 2023-05-10 (Crawled : 12:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 1.84%
H: 9.32%
C: 8.6%
conference global therapeutics
ADC Therapeutics to Host First Quarter 2023 Financial Results Conference Call on May 9, 2023
Published: 2023-05-02 (Crawled : 12:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -0.51%
H: 0.26%
C: -2.56%
conference therapeutics financial results
ADC Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
Published: 2023-03-01 (Crawled : 14:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 6.67%
H: 0.0%
C: -11.98%
care conference health therapeutics
ADC Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
Published: 2023-02-28 (Crawled : 14:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -3.93%
H: 2.3%
C: -7.93%
year therapeutics financial results
ADC Therapeutics to Host Fourth Quarter and Year-End 2022 Financial Results Conference Call on February 28, 2023
Published: 2023-02-21 (Crawled : 13:20) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -1.84%
H: 0.59%
C: -0.7%
conference therapeutics financial results
ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder
Published: 2023-02-02 (Crawled : 13:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 2.75%
H: 2.68%
C: -12.5%
offering therapeutics
ADC Therapeutics to Participate in February Investor Conferences
Published: 2023-02-01 (Crawled : 13:20) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 1.57%
H: 5.68%
C: 5.01%
therapeutics
ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-04 (Crawled : 13:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -3.34%
H: 2.02%
C: -0.58%
conference therapeutics
ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Published: 2022-12-21 (Crawled : 09:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 14.15%
H: 1.93%
C: -16.25%
zynlonta treatment approval therapeutics
ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer
Published: 2022-12-19 (Crawled : 13:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -0.92%
H: 0.31%
C: -5.59%
therapeutics financial
FREENOME PRESENTS RESEARCH HIGHLIGHTING THE PROMISE OF IDENTIFYING DRUG-RESPONSE BIOMARKERS FOR DLBCL PATIENTS
Published: 2022-12-12 (Crawled : 19:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 1.29%
H: 1.91%
C: -1.27%
research promise biomarkers
Biocytogen Enters into Antibody Agreement with ADC Therapeutics
Published: 2022-11-28 (Crawled : 16:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -0.84%
H: 2.53%
C: -4.49%
antibody therapeutics agreement
ADC Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
Published: 2022-11-08 (Crawled : 13:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 10.8%
H: 0.0%
C: -12.29%
therapeutics financial results
Movers & Shakers: Ambrx, ADC Therapeutics, ImmunoGen and More get New C-Suites
Published: 2022-11-04 (Crawled : 13:20) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 1.37%
H: 1.81%
C: -4.51%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: -1.33%
H: 4.6%
C: 2.98%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.64%
H: 0.17%
C: -7.01%
GOSS 4 | $0.7837 -2.77% -2.85% 670K
|
Health Technology
|
| O: -1.89%
H: 1.63%
C: 1.15%
DCTH | $4.87 3.73% 3.59% 300K
|
Health Technology
|
| O: 0.36%
H: 1.43%
C: 1.43%
CDXS | $2.815 0.54% 0.53% 470K
|
Process Industries
|
| O: 9.28%
H: 4.17%
C: 1.6%
BWAY | $4.835 0.94% 0.93% 41K
|
Health Technology
|
| O: -4.31%
H: 1.87%
C: 0.7%
ANGO | $6.26 2.29% 2.24% 480K
|
Health Technology
|
| O: 1.7%
H: 2.33%
C: 2.11%
ADXS | $0.57 12.48% 9.5K
|
Health Technology
|
| O: 15.15%
H: 10.53%
C: 5.26%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 3.79%
H: 0.0%
C: -4.38%
BioSpace Movers & Shakers: Ambrx, ADC Therapeutics, ImmunoGen and More Get Ne...
Published: 2022-11-04 (Crawled : 12:20) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: 1.37%
H: 1.81%
C: -4.51%
KMDA | News | $5.05 -0.98% -0.99% 27K
|
Health Technology
|
| O: -1.33%
H: 4.6%
C: 2.98%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.64%
H: 0.17%
C: -7.01%
GOSS 4 | $0.7837 -2.77% -2.85% 670K
|
Health Technology
|
| O: -1.89%
H: 1.63%
C: 1.15%
DCTH | $4.87 3.73% 3.59% 300K
|
Health Technology
|
| O: 0.36%
H: 1.43%
C: 1.43%
CDXS | $2.815 0.54% 0.53% 470K
|
Process Industries
|
| O: 9.28%
H: 4.17%
C: 1.6%
BWAY | $4.835 0.94% 0.93% 41K
|
Health Technology
|
| O: -4.31%
H: 1.87%
C: 0.7%
ANGO | $6.26 2.29% 2.24% 480K
|
Health Technology
|
| O: 1.7%
H: 2.33%
C: 2.11%
ADXS | $0.57 12.48% 9.5K
|
Health Technology
|
| O: 15.15%
H: 10.53%
C: 5.26%
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 3.79%
H: 0.0%
C: -4.38%
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 64th ASH Annual Meeting
Published: 2022-11-03 (Crawled : 14:00) - biospace.com/
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -2.44%
H: 5.65%
C: 5.65%
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -2.18%
H: 8.91%
C: 8.17%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -1.73%
H: 4.51%
C: 3.15%
meeting therapeutics presentation
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.